LNAI Financials

Income Statement
MetricQ4 2026Q3 2026Q2 2026
Revenue
31.1K
+48.3%
20.9K
0
Cost of Revenue
0
0
0
Gross Profit
31.1K
+48.3%
20.9K
0
Operating Expenses
2.2M
+49.8%
1.4M
-20.6%
1.8M
R&D
-61708
-487.0%
15.9K
-65.2%
45.9K
SG&A
2.2M
+54.9%
1.4M
-19.5%
1.8M
Operating Income
-2138899
-49.9%
-1427260
+21.7%
-1823414
EBITDA
-2117716
-50.4%
-1407626
+22.3%
-1812231
Net Income
-2010702
+21.8%
-2571394
-42.9%
-1799404
EPS (Basic)
—
$-0.80
-25.0%
$-0.64
EPS (Diluted)
—
$-0.80
-25.0%
$-0.64
Shares (Diluted)
—
3.1M
+6.4%
2.9M
Lunai Bioworks (LNAI) — Financials